Children between the ages of 16 and 17 in the UK are expected to receive a second dose of the Pfizer-BioNTech COVID-19 vaccine shortly, and the government’s independent Vaccine Advisory Board will make a recommendation on Monday.
The Joint Committee on Immunization and Immunization (JCVI) also recommended mRNA booster doses for all adults aged 40-49 years. TV briefing..
The Pfizer-BioNTech vaccine is currently the only CCP (Chinese Communist Party) virus vaccine approved for use in children over the age of 12. JCVI advised children aged 16 to 17 years to be vaccinated once on August 4th.
The Commission on Monday stated that older adolescent groups should receive a second dose at least 12 weeks after the first shot, or at least 12 weeks after a positive test if later than the first shot. ..
In a statement, JCVI suggests that the longer the interval between two injections in Canada and the United Kingdom, the lower the risk of myocarditis or heart inflammation after the second dose.
“The latest available data show that post-vaccination myocarditis usually resolves in a short period of time, responds well to treatment in most cases, and if information is available, major complications are identified in the mid-term (Monday). It shows that it is not. “
UK drug regulators welcomed JCVI’s recommendations and sought to reassure people of the short- to medium-term safety of vaccines under the age of 18.
“We closely monitored the safety of COVID-19 vaccines in individuals under the age of 18, and reviewing reports of suspicious side effects does not create any additional safety issues specific to this age group,” he said. Dr. June Raine, Chief Pharmaceutical Officer, said. Said the Healthcare Products Regulatory Authority (MHRA) in the same briefing that aired on television Monday.
Long-term vaccine safety data have not yet been accumulated. Rein urged people to continue reporting suspicious side effects to the CCP virus vaccine through the MHRA Yellow Card Scheme.
Asked about the low vaccination rate of children in the UK, Rain and JCVI professor Wei Shen Lim said they are now relieved that the vaccine “looks much safer than initially feared.”
England’s Deputy Chief Medical Officer, Jonathan Vantam, agreed with Rain and Lim, adding that parents and children had to decide for themselves.
“We should give them time and space and give them the highest quality information so they can make those decisions in their own time,” Vantam said.
JCVI also extended the recommendation of the mRNA booster vaccine to all adults over the age of 40 as the effects of the first two doses diminished.
Pfizer-BioNTech and Moderna COVID-19 vaccines are recommended to be boosted 6 months after the second dose, regardless of the first or second dose.
Lim said it is a normal practice to halve the dose of follow-up vaccination, as is done with the Moderna booster shot, “half the booster dose is in the UK. It is also expected to be associated with a reduction in adverse events. “